CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
ergocalciferol (vitamin D2) +2 moredrug
Likely dose
ergocalciferol (vitamin D2) 50,000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00450073
NCT00450073N/ACompleted
CompareCT.gov

Desktop Tanning Unit to Improve Vitamin D Status in Patients With Cystic Fibrosis and Short Bowel Syndrome: A Pilot Study

Atlanta VA Medical Center·interventional·Posted Mar 21, 2007·Updated Feb 21, 2014

In Brief

A clinical study evaluating ergocalciferol (vitamin D2), Sperti Del Sol Lamp, and 1 other intervention for Cystic Fibrosis. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The purpose of this study is to establish an effective method to correct vitamin D deficiency in subjects with cystic fibrosis. The investigators will examine cholecalciferol, ergocalciferol and UV light.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis
CountriesUnited States
CollaboratorsEmory University

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 21, 2007
Enrollment StartNov 1, 2006
Primary CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 19.3 years ago

Interventions

ergocalciferol (vitamin D2)drug

50,000 IU weekly

Sperti Del Sol Lampdevice

5 times a week for 12 weeks

Vitamin D3drug

50,000 IU weekly